Egypt Breast Cancer Diagnostics Market to be Dominated by the Hospitals & Clinics Segment by 2028

Growing technological advancement in cancer diagnostic and screening technologies is expected to drive Egypt Breast Cancer Diagnostics Market in the forecast period, 2024-2028.

According to TechSci Research report, “Egypt Breast Cancer Diagnostics Market– By Region, Competition, Forecast and Opportunities, 2028”, the Egypt Breast Cancer Diagnostics Market is anticipated to grow at a steady rate in the forecast period, 2024-2028. The growth is attributed to rising prevalence of breast cancer and growing government offerings and initiatives to increase the screening and diagnosis of breast cancer among women in the country. According to the World Bank data, as of 2021, the female population of Egypt is projected as 54.9 million. According to World Health Organization (WHO), In Egypt, breast cancer is the most common cause of cancer mortality in women. Egypt has a value of 57/100 on the index of effective coverage in breast cancer treatment.

The growing incidence of breast cancer can be attributed to various factors, including changing lifestyle habits, increased exposure to environmental toxins, and a lack of awareness and early detection. Also, according to Globocan 2020, breast cancer is the second most prevalent cancer cases, causing 9148 new deaths and is thus among the most prevalent cancer among women in Egypt. Studies have shown that there is a higher prevalence of genetic mutations associated with breast cancer in some regions of Egypt. Lifestyle factors including diet, physical activity, and obesity, can contribute to the risk of developing breast cancer. According to a Paper published in National Library of medicine, in 2019, in Egypt, the traditional diet in the country is fat rich and is lower in fruits and vegetables inclusion, which may increase the risk of breast cancer. Sedentary lifestyle and physical inactivity along with obesity are contributing factors for breast cancer.

Also, one of the major factors leading to breast cancer cases is the imbalance in hormones in women’s’ body. Hormonal factors, such as early onset of menstruation, late menopause, and not having children or having them at an older age, can increase the risk of breast cancer. The Lack of awareness and  no pre diagnosis for breast cancer is a leading cause for developing more cases of breast cancer in women across the country. In Egypt, lack of awareness and early detection is causing women to suffer breast cancer, and, in many cases, it is detected at a late stage, thereby causing issues in treatment later on. Many women do not undergo regular screenings for breast cancer, and the disease often goes undiagnosed until it has reached an advanced stage.

Advancement in technology for screening and diagnostic for breast cancer such as introduction of digital mammography, a new technology that uses digital images to screen for breast cancer. This method has several advantages over traditional film mammography, including better image quality, faster results, and lower radiation exposure. Digital mammography is now widely available in Egypt, and many clinics and hospitals have adopted this technology. Also, 3D mammography, referred as tomosynthesis, is another new technology that is becoming increasingly popular in Egypt. This method creates three-dimensional images of the breast, allowing doctors to detect small tumors that may be missed by traditional mammography. 3D mammography is particularly useful for women with dense breast tissue, who may be at higher risk of breast cancer and thus is one of the efficient techniques to diagnose breast cancer at an early stage. This early detection is contributing to the growing demand of screening and diagnostic techniques in breast cancer diagnostic techniques.

Moreover, among the major challenges factors such as addressing breast cancer in Egypt is the lack of awareness about the disease and its risk factors. Many women in Egypt do not undergo regular screenings for breast cancer, and the disease often goes undiagnosed until it has reached an advanced stage. Moreover, there is a stigma associated with breast cancer in Egypt, and many women are reluctant to seek medical help or talk about their symptoms.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on " Egypt Breast Cancer Diagnostics Market.”

Based on type, the market is segmented into imaging, biopsy, genomic tests, and blood tests. The imaging segment is dominating the market in 2022 and is expected to hold the highest market share in the forecast period. This is attributed to the growing screening and diagnostic testing generally to increase the chances of getting the diseases diagnosed in the earlier stages if present in the person.

Based on application, the market is segmented into screening diagnostic & predictive, prognostic, and research. The diagnostic & predictive segment dominated in 2022 and is expected to hold the highest share in the forecast period. This is due to the increasing genetic testing among patients to test the onset of breast cancer at an earlier stage. Moreover, development of advancement such as biomarker is significant and is contributing to the growth of the diagnostic & predictive segment in the Egypt breast cancer diagnostic market.

Major companies operating in the Egypt Breast Cancer Diagnostics Market are:

         ·         AstraZeneca

         ·          Pfizer Inc

         ·         Sanofi

         ·         Bristol Myers Squiib

         ·         Merck & Co

         ·         Novartis AG

         ·         Eli Lilly and Company

         ·         Fresenius Kabi

         ·         GlaxoSmithKline Egypt

         ·         GE Healthcare Egypt

Download Sample Report

Customers can also request for 10% free customization on this report.

“The country undergoing adoption of advanced diagnostic techniques such as digital mammography for breast cancer diagnostics are expected to dominate the Egypt Breast Cancer Diagnostics Market. Also, besides techniques such as biopsy, genetic testing, breast MRI, and breast ultrasound, etc. are increasing the early diagnosis in the country and  is further  influencing to support the market growth in the country” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.

“Egypt Breast Cancer Diagnostics Market, By Product (Platform-based, Instrument-based), By Type (Imaging, Biopsy, Genomic Tests, Blood Tests), By Application (Screening Diagnostic & Predictive, Prognostic, Research), By End-use(Hospitals & Clinics, Diagnostic Centers, Medical Laboratories, Others) By Region, Competition Forecast & Opportunities, 2028”, has evaluated the future growth potential of Egypt Breast Cancer Diagnostics Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Egypt Breast Cancer Diagnostics Market.

Website: https://www.techsciresearch.com